168 related articles for article (PubMed ID: 12477050)
1. Inhibition of cell growth by NB1011 requires high thymidylate synthase levels and correlates with p53, p21, bax, and GADD45 induction.
Neuteboom ST; Karjian PL; Boyer CR; Beryt M; Pegram M; Wahl GM; Shepard HM
Mol Cancer Ther; 2002 Apr; 1(6):377-84. PubMed ID: 12477050
[TBL] [Abstract][Full Text] [Related]
2. NB1011 induces Ser15 phosphorylation of p53 and activates the G2/M checkpoint.
Dellinger RW; Karjian PL; Neuteboom ST
Anticancer Drugs; 2003 Jul; 14(6):449-55. PubMed ID: 12853888
[TBL] [Abstract][Full Text] [Related]
3. Nucleoside transport inhibitors, dipyridamole and p-nitrobenzylthioinosine, selectively potentiate the antitumor activity of NB1011.
Boyer CR; Karjian PL; Wahl GM; Pegram M; Neuteboom ST
Anticancer Drugs; 2002 Jan; 13(1):29-36. PubMed ID: 11914638
[TBL] [Abstract][Full Text] [Related]
4. A novel approach to thymidylate synthase as a target for cancer chemotherapy.
Li Q; Boyer C; Lee JY; Shepard HM
Mol Pharmacol; 2001 Mar; 59(3):446-52. PubMed ID: 11179438
[TBL] [Abstract][Full Text] [Related]
5. Molecular downstream events and induction of thymidylate synthase in mutant and wild-type p53 colon cancer cell lines after treatment with 5-fluorouracil and the thymidylate synthase inhibitor raltitrexed.
Peters GJ; van Triest B; Backus HH; Kuiper CM; van der Wilt CL; Pinedo HM
Eur J Cancer; 2000 May; 36(7):916-24. PubMed ID: 10785598
[TBL] [Abstract][Full Text] [Related]
6. Involvement of bcl-2 and p21waf1 proteins in response of human breast cancer cell clones to Tomudex.
Orlandi L; Bearzatto A; Abolafio G; De Marco C; Daidone MG; Zaffaroni N
Br J Cancer; 1999 Sep; 81(2):252-60. PubMed ID: 10496350
[TBL] [Abstract][Full Text] [Related]
7. Cellular transformation of the investigational new anticancer drug NB1011, a phosphoramidate of 5-(2-bromovinyl)-2'-deoxyuridine, results in modification of cellular proteins not DNA.
Sergeeva MV; Cathers BE
Biochem Pharmacol; 2003 Mar; 65(5):823-31. PubMed ID: 12628478
[TBL] [Abstract][Full Text] [Related]
8. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
Goldwasser F; Bae I; Fornace AJ; Pommier Y
Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795
[TBL] [Abstract][Full Text] [Related]
9. DNA damage and p53 induction do not cause ZD1694-induced cell cycle arrest in human colon carcinoma cells.
Matsui SI; Arredondo MA; Wrzosek C; Rustum YM
Cancer Res; 1996 Oct; 56(20):4715-23. PubMed ID: 8840989
[TBL] [Abstract][Full Text] [Related]
10. Specific induction of gadd45 in human melanocytes and melanoma cells after UVB irradiation.
Pedeux R; Lefort K; Cuenin C; Cortes U; Kellner K; Doré JF; Nakazawa H
Int J Cancer; 2002 Apr; 98(6):811-6. PubMed ID: 11948456
[TBL] [Abstract][Full Text] [Related]
11. Acute and delayed apoptosis induced by thymidine deprivation correlates with expression of p53 and p53-regulated genes in colon carcinoma cells.
Harwood FG; Frazier MW; Krajewski S; Reed JC; Houghton JA
Oncogene; 1996 May; 12(10):2057-67. PubMed ID: 8668331
[TBL] [Abstract][Full Text] [Related]
12. Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas.
Bukholm IK; Nesland JM
Virchows Arch; 2000 Mar; 436(3):224-8. PubMed ID: 10782880
[TBL] [Abstract][Full Text] [Related]
13. Enzyme-catalyzed therapeutic agent (ECTA) design: activation of the antitumor ECTA compound NB1011 by thymidylate synthase.
Lackey DB; Groziak MP; Sergeeva M; Beryt M; Boyer C; Stroud RM; Sayre P; Park JW; Johnston P; Slamon D; Shepard HM; Pegram M
Biochem Pharmacol; 2001 Jan; 61(2):179-89. PubMed ID: 11163332
[TBL] [Abstract][Full Text] [Related]
14. Regulation of p53 target gene expression by cisplatin-induced extracellular signal-regulated kinase.
DeHaan RD; Yazlovitskaya EM; Persons DL
Cancer Chemother Pharmacol; 2001 Nov; 48(5):383-8. PubMed ID: 11761456
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents.
O'Connor PM; Jackman J; Bae I; Myers TG; Fan S; Mutoh M; Scudiero DA; Monks A; Sausville EA; Weinstein JN; Friend S; Fornace AJ; Kohn KW
Cancer Res; 1997 Oct; 57(19):4285-300. PubMed ID: 9331090
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.
Ramondetta L; Mills GB; Burke TW; Wolf JK
Clin Cancer Res; 2000 Jan; 6(1):278-84. PubMed ID: 10656459
[TBL] [Abstract][Full Text] [Related]
17. Differences in induction of p53, p21WAF1 and apoptosis in relation to cell cycle phase of MCF-7 cells treated with camptothecin.
Deptala A; Li X; Bedner E; Cheng W; Traganos F; Darzynkiewicz Z
Int J Oncol; 1999 Nov; 15(5):861-71. PubMed ID: 10536167
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle regulation of the G0/G1 transition in 5-fluorouracil-sensitive and -resistant human colon cancer cell lines.
McGinn CJ; Pestalozzi BC; Drake JC; Glennon MC; Kunugi K; Otterson G; Allegra CJ; Johnston PG; Kinsella TJ
Cancer J; 2000; 6(4):234-42. PubMed ID: 11038143
[TBL] [Abstract][Full Text] [Related]
19. Signaling pathways of apoptosis activated by aromatase inhibitors and antiestrogens.
Thiantanawat A; Long BJ; Brodie AM
Cancer Res; 2003 Nov; 63(22):8037-50. PubMed ID: 14633737
[TBL] [Abstract][Full Text] [Related]
20. Ketoconazole potentiates the antitumor effects of nocodazole: In vivo therapy for human tumor xenografts in nude mice.
Wang YJ; Jeng JH; Chen RJ; Tseng H; Chen LC; Liang YC; Lin CH; Chen CH; Chu JS; Ho WL; Ho YS
Mol Carcinog; 2002 Aug; 34(4):199-210. PubMed ID: 12203371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]